Sleeve Gastrectomy Slows Obesity Progression in Prader-Willi Syndrome Children
A 5-year study finds bariatric surgery offers meaningful but attenuated weight loss in PWS kids versus lifestyle intervention alone.
Summary
Prader-Willi syndrome (PWS) causes severe, difficult-to-treat obesity driven by uncontrollable hunger. Researchers at a major Italian children's hospital followed 16 PWS patients who underwent sleeve gastrectomy — a surgical procedure that reduces stomach size — for five years, comparing them to matched non-syndromic obese patients and PWS patients treated with lifestyle changes only. Surgery produced meaningful early weight loss in PWS, but the benefit faded significantly by year five. Still, it dramatically outperformed lifestyle intervention alone, which led to progressive weight gain and worsening health complications. The findings suggest that while surgery is far less effective in PWS than in typical obesity, it may still be a valuable tool for altering the disease's otherwise deteriorating course in carefully selected young patients.
Detailed Summary
Prader-Willi syndrome is one of the most challenging obesity-related genetic conditions, characterized by insatiable hyperphagia, hormonal dysregulation, and metabolic complications that begin in childhood. Traditional dietary and lifestyle interventions rarely prevent progressive, severe obesity. As a result, clinicians have explored bariatric surgery — including sleeve gastrectomy — as a potential intervention, but long-term pediatric data have been scarce.
This single-center Italian study retrospectively analyzed outcomes in 16 pediatric and transition-age PWS patients who underwent laparoscopic sleeve gastrectomy (LSG), comparing them to 32 matched non-syndromic obese patients who also had LSG and 16 PWS patients managed with lifestyle intervention alone. The primary outcome was change in BMI standard deviation score (BMI-SDS) over five years.
In the PWS surgical group, BMI-SDS fell from 5.18 to an early nadir at one to two years, representing approximately a 26% reduction. However, significant weight regain followed, and by year five the improvement was only 16.9% — far below the 57.4% sustained reduction seen in non-syndromic peers. Obesity-related comorbidities did decline modestly in the PWS surgery group. In stark contrast, the PWS lifestyle-only group saw BMI-SDS rise by 36.4% over five years, along with a meaningful increase in cardiometabolic complications.
The clinical implication is nuanced: surgery does not normalize weight trajectory in PWS, but when the comparator is progressive, uncontrolled obesity, even a partial and attenuated benefit may meaningfully change a patient's long-term health trajectory and quality of life.
Important caveats include the small sample size, retrospective design, single-center setting, and the fact that this summary is based on the abstract only, limiting insight into procedural details, adverse events, and hormonal outcomes. These findings should be interpreted cautiously and prospective multicenter trials are needed.
Key Findings
- PWS patients achieved ~26% BMI-SDS reduction after surgery, but regained much weight; only 16.9% improvement remained at 5 years.
- Non-syndromic obese peers had 57.4% BMI-SDS improvement at 5 years — more than triple the PWS surgical response.
- PWS patients on lifestyle intervention alone saw BMI-SDS worsen by 36.4%, highlighting surgery's relative benefit.
- Obesity-related comorbidities decreased in both surgical groups but increased in the PWS lifestyle-only group.
- Sleeve gastrectomy appears to alter the disease trajectory in PWS, even if long-term weight loss is limited.
Methodology
This is a single-center, retrospective longitudinal cohort study from Bambino Gesù Children's Hospital in Rome, reviewing electronic health records of 110 PWS patients and 268 LSG candidates. The study included 16 PWS-LSG patients, 32 matched non-syndromic OB-LSG controls, and 16 PWS-lifestyle-only controls followed over five years.
Study Limitations
The study is small (16 PWS surgical patients), retrospective, and conducted at a single center, limiting generalizability and statistical power. The non-randomized design introduces selection bias, and the lifestyle comparison group had a notably lower baseline BMI-SDS. This summary is based on the abstract only, so details on adverse events, hormonal outcomes, and procedural specifics are unavailable.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.